This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Choroideremia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Choroideremia shares some biological mechanisms with abnormal-degeneration, abnormal-degeneration, age-related-macular-degeneration, atrophy, atrophy, blind-vision, blind-vision, chorioretinal-atrophy, chorioretinal-atrophy, choroideremia, complete-hearing-loss, complete-hearing-loss, disorder-of-eye, disorder-of-eye, dystrophy, dystrophy, gyrate-atrophy, gyrate-atrophy, macule, macule, night-blindness, night-blindness, retinal-degeneration, retinal-degeneration, retinal-diseases, retinal-diseases, retinal-dystrophies, retinal-dystrophies, retinitis-pigmentosa, retinitis-pigmentosa, sex-chromosome-aberrations, sex-chromosome-aberrations, usher-syndrome, usher-syndrome, uveal-diseases, uveal-diseases.
Among the many pathways, these few ones have gauged particular interests from scientists studying Choroideremia, and have been seen in publications frequently: Cell Activation, Cell Activation, Cell Adhesion, Cell Adhesion, Cell Death, Immune Response, Immune Response, Lipid Modification, Lipid Modification, Localization, Localization, Membrane Fusion, Mrna Splicing, Mrna Splicing, Pathogenesis, Pathogenesis, Phagocytosis, Phagosome-lysosome Fusion, Phagosome-lysosome Fusion, Pigmentation, Pigmentation, Prenylation, Prenylation, Proteolysis, Proteolysis, Reflex, Reflex, Regulation Of Protein Localization, Regulation Of Protein Localization, Reverse Transcription, Reverse Transcription, Secretion, Secretion, Translation, Translation, Transport, Transport, Vasculogenesis, Vesicle Transport, Vesicle Transport
Quite a number of genes have been found to play important roles in Choroideremia, such as AGFG1, AGFG1, CCL2, CHM, CHM, CHML, CHML, ERG, ERG, KCNH2, KCNH2, KCNMA1, KCNMA1, MPZ, MPZ, OAT, OAT, POU3F4, POU3F4, PRPH, RAB1A, RAB1A, RAB27A, RAB27A, RBP3, RBP3, RHO, RHO, RPE, RPE, RPE65. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.